Rochem Methotrexate Rochem Methotrexate

X

List of Suppliers' Film Formers Plasticizers Excipients Application used in Methotrexate on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

LM Application #LearnMore
Applications:
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Ingredient(s): Hypromellose
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP/BP/EP/CP
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Applications:
Ingredient(s): Propylene Glycol
Route of Administration (Grade): Topical and Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Applications:
Ingredient(s): polyethylene glycol
Route of Administration (Grade): Topical and Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Polysorbate 80
Route of Administration (Grade): Topical, Oral
Pharmacopoeia Reference: Ph.Eur, USP-NF
Technical Specifications: HLB: 15, EO: 20; EXCiPACT
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Ingredient(s): polyethylene glycol
Category: Topical
Route of Administration (Grade): Topical, Parenteral
Pharmacopoeia Reference: Not Available
Technical Specifications: Low Endotoxin
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP, EP, JP; Having US-DMF
Technical Specifications: Moisture barrier film coating system
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
LM Application #LearnMore
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP, EP, JP; Having US-DMF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LM Application #LearnMore
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5MG BASE/ML
  • INJECTABLE;INJECTION - EQ 20MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 25MG BASE/ML
  • INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INJECTION - EQ 50MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)
  • SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)
  • SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)
  • SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)
  • SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)
  • SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)
  • SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)
  • TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY